INSM

Insmed Incorporated (INSM)

Last Price$81.1(3.0%)
Market Cap$14.5B
LTM Cash & Cash Equivalents
$555.0M
YoY Growth
+15.1%
3Y CAGR
-8.2%
5Y CAGR
+2.6%
Stock quality & Intrinsic value
6/10
51.1% overvalued

Insmed Incorporated Cash & Cash Equivalents

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Cash & Cash Equivalents
$9,222.0K
$18.8M
$24.1M
$16.5M
$2,145.0K
$12.7M
$10.7M
$14.8M
$90.8M
$113.9M
$159.2M
$282.9M
$162.6M
$381.2M
$495.1M
$487.4M
$532.8M
$716.8M
$1,074.0M
$482.4M
INSM
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for INSM and see if it's the right time to invest.
Dive in

Insmed Incorporated (INSM) Cash & Cash Equivalents comparison analysis

Crunching data... Almost there!

INSM key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Insmed Incorporated's Cash & Cash Equivalents?

As of today, Insmed Incorporated's last 12-month Cash & Cash Equivalents is $555.0M, based on the financial report for Dec 31, 2024 (Q4 2024).

2) What is Insmed Incorporated's Cash & Cash Equivalents growth rate?

Over the last year, Insmed Incorporated's Cash & Cash Equivalents growth was 15.1%. The average annual Cash & Cash Equivalents growth rates for Insmed Incorporated have been (15.8%) over the past three years, 2.6% over the past five years.

3) Is Insmed Incorporated's Cash & Cash Equivalents growth rate Good?

Over the last year, Insmed Incorporated's Cash & Cash Equivalents growth was 15.1%, which is higher than industry growth of (0.1%). It indicates that Insmed Incorporated's Cash & Cash Equivalents growth is Good.

4) How does Insmed Incorporated's Cash & Cash Equivalents growth rate compare to its peers?

Over the last year, Insmed Incorporated's Cash & Cash Equivalents growth was 15.1%, which is higher than peer median growth of (33.3%). The list of peers includes BNTX, VRTX, BGNE, NVO, INCY, UTHR, ALNY, SMMT, REGN, ARGX etc.